Summit Therapeutics
SMMT
$4.68
Share price
-2.40%
Change (1 day)
156.01%
Change (1 year)
Categories
Market capitalization of Summit Therapeutics (SMMT)
Market cap: $3.28 Billion
As of May 2024 Summit Therapeutics has a market cap of $3.28 Billion. This makes Summit Therapeutics the world's 3341th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Summit Therapeutics from 2015 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $3.28 B | 79.79% |
| 2023 | $1.82 B | 113.79% |
| 2022 | $0.85 B | 225.51% |
| 2021 | $0.26 B | -32.01% |
| 2020 | $0.38 B | 259.7% |
| 2019 | $0.10 B | 468.07% |
| 2018 | $18.92 M | -88.56% |
| 2017 | $0.16 B | 57.11% |
| 2016 | $0.10 B | -25.33% |
| 2015 | $0.14 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of Summit Therapeutics was reported to be:
$3.28 Billion
$3.28 Billion
$3.28 Billion
$3.28 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $12.53 B | 281.28% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.21 B | -93.32% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | $0.23 B | -92.74% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | $6.16 B | 87.47% | 🇺🇸 USA |